(+)-dexrazoxane increases expression ISO RGD:1622341 6480464 Dexrazoxane results in increased expression of ATP5MF mRNA CTD PMID:26873546 1,2-dichloroethane decreases expression ISO RGD:1622341 6480464 ethylene dichloride results in decreased expression of ATP5MF mRNA CTD PMID:28960355 1,2-dimethylhydrazine multiple interactions ISO RGD:1622341 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATP5MF mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO RGD:1622341 6480464 1, 2-Dimethylhydrazine results in decreased expression of ATP5MF mRNA CTD PMID:22206623 17alpha-ethynylestradiol multiple interactions ISO RGD:1622341 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ATP5MF mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:1622341 6480464 Ethinyl Estradiol results in increased expression of ATP5MF mRNA CTD PMID:17942748 17beta-estradiol decreases expression ISO RGD:1345847 6480464 Estradiol results in decreased expression of ATP5MF mRNA CTD PMID:23019147 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1622341 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1622341 6480464 [2 more ... CTD PMID:25510870 2,2,2-tetramine multiple interactions EXP 6480464 Trientine inhibits the reaction [Streptozocin results in increased expression of ATP5MF protein] CTD PMID:19634143 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1622341 6480464 Tetrachlorodibenzodioxin results in decreased expression of ATP5MF mRNA CTD PMID:21354282 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ATP5MF mRNA CTD PMID:33387578 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1622341 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ATP5MF mRNA CTD PMID:17942748 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1345847 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of ATP5MF mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ATP5MF mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1345847 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of ATP5MF mRNA CTD PMID:28628672 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of ATP5MF mRNA CTD PMID:30047161 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of ATP5MF mRNA CTD PMID:31881176 amitrole increases expression EXP 6480464 Amitrole results in increased expression of ATP5MF mRNA CTD PMID:30047161 ampicillin multiple interactions EXP 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ATP5MF protein CTD PMID:30545405 aristolochic acid A increases expression ISO RGD:1345847 6480464 aristolochic acid I results in increased expression of ATP5MF mRNA CTD PMID:33212167 Aroclor 1254 increases expression ISO RGD:1622341 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of ATP5MF mRNA CTD PMID:23650126 atrazine decreases expression ISO RGD:1345847 6480464 Atrazine results in decreased expression of ATP5MF mRNA CTD PMID:22378314 bisphenol A multiple interactions EXP 6480464 [Fructose co-treated with bisphenol A] results in decreased expression of ATP5MF protein CTD PMID:26930160 bisphenol A multiple interactions ISO RGD:1345847 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of ATP5MF gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:1622341 6480464 bisphenol A results in increased expression of ATP5MF mRNA CTD PMID:33221593 bisphenol A affects expression ISO RGD:1345847 6480464 bisphenol A affects the expression of ATP5MF mRNA CTD PMID:30903817 bisphenol A decreases expression ISO RGD:1345847 6480464 bisphenol A results in decreased expression of ATP5MF mRNA CTD PMID:29275510 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ATP5MF mRNA CTD PMID:30903817 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ATP5MF mRNA CTD PMID:25181051 bisphenol F multiple interactions ISO RGD:1345847 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ATP5MF mRNA CTD PMID:28628672 caffeine decreases expression ISO RGD:1345847 6480464 Caffeine results in decreased expression of ATP5MF mRNA CTD PMID:11793227 chloropicrin increases expression ISO RGD:1345847 6480464 chloropicrin results in increased expression of ATP5MF mRNA CTD PMID:26352163 clobetasol increases expression ISO RGD:1622341 6480464 Clobetasol results in increased expression of ATP5MF mRNA CTD PMID:27462272 cobalt dichloride decreases expression ISO RGD:1345847 6480464 cobaltous chloride results in decreased expression of ATP5MF mRNA CTD PMID:19376846 copper(II) sulfate decreases expression ISO RGD:1345847 6480464 Copper Sulfate results in decreased expression of ATP5MF mRNA CTD PMID:19549813 cyclosporin A decreases expression ISO RGD:1345847 6480464 Cyclosporine results in decreased expression of ATP5MF mRNA CTD PMID:20106945 , PMID:25562108 dexamethasone multiple interactions ISO RGD:1345847 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of ATP5MF mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ATP5MF mRNA CTD PMID:28628672 dibutyl phthalate decreases expression ISO RGD:1622341 6480464 Dibutyl Phthalate results in decreased expression of ATP5MF mRNA CTD PMID:21266533 diethylstilbestrol decreases expression ISO RGD:1345847 6480464 Diethylstilbestrol results in decreased expression of ATP5MF mRNA CTD PMID:36621641 dimethyl sulfoxide affects expression ISO RGD:1345847 6480464 Dimethyl Sulfoxide affects the expression of ATP5MF mRNA CTD PMID:24834073 diuron decreases expression ISO RGD:1345847 6480464 Diuron results in decreased expression of ATP5MF mRNA CTD PMID:35967413 doxorubicin increases expression ISO RGD:1345847 6480464 Doxorubicin results in increased expression of ATP5MF mRNA CTD PMID:29803840 epoxiconazole increases expression ISO RGD:1622341 6480464 epoxiconazole results in increased expression of ATP5MF mRNA CTD PMID:35436446 folic acid multiple interactions ISO RGD:1622341 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATP5MF mRNA CTD PMID:22206623 fructose multiple interactions EXP 6480464 [Fructose co-treated with bisphenol A] results in decreased expression of ATP5MF protein CTD PMID:26930160 fructose increases expression EXP 6480464 Fructose results in increased expression of ATP5MF protein CTD PMID:26930160 fulvestrant multiple interactions ISO RGD:1345847 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of ATP5MF gene CTD PMID:31601247 gentamycin multiple interactions EXP 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ATP5MF protein CTD PMID:30545405 glycidyl methacrylate decreases expression ISO RGD:1345847 6480464 glycidyl methacrylate results in decreased expression of ATP5MF protein CTD PMID:36641056 hydrogen sulfide decreases expression ISO RGD:1622341 6480464 Hydrogen Sulfide results in decreased expression of ATP5MF protein CTD PMID:29932956 indometacin multiple interactions ISO RGD:1345847 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of ATP5MF mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ATP5MF mRNA CTD PMID:28628672 isotretinoin decreases expression ISO RGD:1345847 6480464 Isotretinoin results in decreased expression of ATP5MF mRNA CTD PMID:20436886 ivermectin decreases expression ISO RGD:1345847 6480464 Ivermectin results in decreased expression of ATP5MF protein CTD PMID:32959892 lamivudine multiple interactions ISO RGD:1622341 6480464 [Zidovudine co-treated with Lamivudine] results in increased expression of ATP5MF mRNA CTD PMID:18313992 lipopolysaccharide multiple interactions ISO RGD:1345847 6480464 [Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of ATP5MF mRNA CTD PMID:31059760 methimazole increases expression EXP 6480464 Methimazole results in increased expression of ATP5MF mRNA CTD PMID:30047161 methyl methanesulfonate decreases expression ISO RGD:1345847 6480464 Methyl Methanesulfonate results in decreased expression of ATP5MF mRNA CTD PMID:23649840 metronidazole multiple interactions EXP 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ATP5MF protein CTD PMID:30545405 neomycin multiple interactions EXP 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ATP5MF protein CTD PMID:30545405 niclosamide decreases expression ISO RGD:1345847 6480464 Niclosamide results in decreased expression of ATP5MF mRNA CTD PMID:22576131 paracetamol decreases expression ISO RGD:1345847 6480464 Acetaminophen results in decreased expression of ATP5MF mRNA CTD PMID:11793227 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of ATP5MF mRNA CTD PMID:33387578 paracetamol multiple interactions ISO RGD:1345847 6480464 [Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of ATP5MF mRNA CTD PMID:31059760 PCB138 multiple interactions ISO RGD:1622341 6480464 [2 more ... CTD PMID:25510870 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1622341 6480464 perfluorooctane sulfonic acid results in decreased expression of ATP5MF mRNA CTD PMID:20936131 pirinixic acid increases expression ISO RGD:1622341 6480464 pirinixic acid results in increased expression of ATP5MF mRNA CTD PMID:20936131 Propiverine affects binding EXP 6480464 propiverine binds to ATP5MF protein CTD PMID:29273565 quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of ATP5MF mRNA CTD PMID:17103110 sodium arsenite increases expression ISO RGD:1345847 6480464 sodium arsenite results in increased expression of ATP5MF mRNA CTD PMID:28595984 , PMID:34032870 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of ATP5MF protein CTD PMID:19634143 streptozocin affects expression ISO RGD:1622341 6480464 Streptozocin affects the expression of ATP5MF mRNA CTD PMID:18583417 streptozocin multiple interactions EXP 6480464 Trientine inhibits the reaction [Streptozocin results in increased expression of ATP5MF protein] CTD PMID:19634143 sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of ATP5MF mRNA CTD PMID:30047161 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of ATP5MF mRNA CTD PMID:33387578 thapsigargin decreases expression ISO RGD:1345847 6480464 Thapsigargin results in decreased expression of ATP5MF mRNA CTD PMID:22378314 thioacetamide decreases expression ISO RGD:1345847 6480464 Thioacetamide results in decreased expression of ATP5MF mRNA CTD PMID:11793227 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of ATP5MF mRNA CTD PMID:34492290 tolcapone affects binding EXP 6480464 tolcapone binds to ATP5MF protein CTD PMID:19783845 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of ATP5MF mRNA CTD PMID:33387578 triptonide increases expression ISO RGD:1622341 6480464 triptonide results in increased expression of ATP5MF mRNA CTD PMID:33045310 tungsten increases expression ISO RGD:1622341 6480464 Tungsten results in increased expression of ATP5MF mRNA CTD PMID:30912803 tunicamycin decreases expression ISO RGD:1345847 6480464 Tunicamycin results in decreased expression of ATP5MF mRNA CTD PMID:22378314 urethane decreases expression ISO RGD:1345847 6480464 Urethane results in decreased expression of ATP5MF mRNA CTD PMID:28818685 valproic acid decreases expression ISO RGD:1345847 6480464 Valproic Acid results in decreased expression of ATP5MF mRNA CTD PMID:29501571 valproic acid increases methylation ISO RGD:1345847 6480464 Valproic Acid results in increased methylation of ATP5MF gene CTD PMID:29154799 , PMID:29501571 vanadium atom increases expression ISO RGD:1345847 6480464 Vanadium results in increased expression of ATP5MF mRNA CTD PMID:19000753 vanadium(0) increases expression ISO RGD:1345847 6480464 Vanadium results in increased expression of ATP5MF mRNA CTD PMID:19000753 vancomycin multiple interactions EXP 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ATP5MF protein CTD PMID:30545405 vincaleukoblastine affects response to substance ISO RGD:1345847 6480464 ATP5MF protein affects the susceptibility to Vinblastine CTD PMID:16217747 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of ATP5MF mRNA CTD PMID:23034163 zidovudine multiple interactions ISO RGD:1622341 6480464 [Zidovudine co-treated with Lamivudine] results in increased expression of ATP5MF mRNA CTD PMID:18313992